STAT3 expression and clinical implications in de novo diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Meeting Abstract
| Authors: | Ok, C. Y.; Xu-Monette, Z.; Tzankov, A.; Visco, C.; Montes, S. M.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W. W. L.; Van Krieken, J. H. J. M.; Huang, Q.; Huh, J.; Ai, W. Z.; Ponzoni, M.; Ferreri, A. J. M.; Farnen, J. P.; Moller, M. B.; Winter, J. N.; Piris, M. A.; Medeiros, L. J.; Young, K. H. |
| Abstract Title: | STAT3 expression and clinical implications in de novo diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385000392 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.365.365 |
| Notes: | Meeting Abstract: 365 -- Source: Wos |
